We are live on
!
Find out more
CC
Callan Capital Portfolio holdings
AUM
$1.35B
1-Year Est. Return
8.35%
This Fund
S&P 500
This Quarter
Est. Return
+6.26%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$864M
AUM Growth
+$54.1M
(+6.7%)
Cap. Flow
+$8.09M
Cap. Flow
% of AUM
0.94%
Top 10 Holdings %
Top 10 Hldgs %
50.84%
Holding
197
New
11
Increased
61
Reduced
63
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$6.54M |
| 2 |
Schwab International Equity ETF
SCHF
|
+$2.93M |
| 3 |
Schwab Fundamental International Large Company Index ETF
FNDF
|
+$2.51M |
| 4 |
Schwab US Broad Market ETF
SCHB
|
+$1.79M |
| 5 |
Avantis US Small Cap Value ETF
AVUV
|
+$1.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$2.53M |
| 2 |
JPMorgan Ultra-Short Municipal Income ETF
JMST
|
+$2.27M |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$1.22M |
| 4 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$1.1M |
| 5 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$803K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 90.85% |
| 2 | Technology | 3.67% |
| 3 | Financials | 1.29% |
| 4 | Healthcare | 1.17% |
| 5 | Real Estate | 0.59% |
Similar funds
MBA
SIA
AP
MW
SBIA
LC
TW
PAME
Callan Capital's Q1 2023 Portfolio in Review
As of Q1 2023, Callan Capital held 197 positions worth $864M, up 6.7% from $810M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Callan Capital's Q1 2023 filing shows 11 new, 61 increased, 63 reduced and 13 closed positions. Its largest new stake was Avantis US Small Cap Value ETF: 22,447 shares worth $1.66M. The largest sale was Jazz Pharmaceuticals, an estimated $2.53M.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, up from 90% a quarter earlier, followed by Technology and Financials.
- Callan Capital's largest Q1 2023 buy was Avantis US Small Cap Value ETF: 22,447 shares worth $1.66M.
- Callan Capital added most to Schwab Fundamental US Large Company Index ETF in Q1 2023, an estimated $6.54M increase.
- Callan Capital's biggest Q1 2023 reduction was JPMorgan Ultra-Short Municipal Income ETF, cutting an estimated $2.27M.
- Callan Capital fully exited Jazz Pharmaceuticals in Q1 2023, selling an estimated $2.53M.
- Callan Capital's ten largest holdings make up 51% of its $864M portfolio in Q1 2023.
- Callan Capital opened 11 new positions and closed 13 in Q1 2023.
- Callan Capital's portfolio value rose 6.7% quarter-over-quarter to $864M.
Based on Callan Capital's 13F filing for Q1 2023, filed 9 May 2023.